There were many surprises in the district of Mistelbach. Due to the crisis at the regional hospital, however, it was ...

Cantor Fitzgerald issued their FY2025 earnings estimates for ARS Pharmaceuticals in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will ...

Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of BridgeBio Pharma in a research report issued to clients and investors on Tuesday, January 21st.

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...